What Researchers Did
This systematic review assessed the effects of various medical and surgical treatments for necrotizing soft tissue infections (NSTIs) in adults within hospital settings.
What They Found
Necrotizing soft tissue infections (NSTIs) are associated with high mortality, estimated at around 23%, and result in disability, sequelae, or limb loss for 15% of patients. The review focused on standard treatments such as antimicrobial therapy, surgical debridement, and intensive care support, but explicitly excluded randomized controlled trials (RCTs) investigating hyperbaric oxygen therapy for NSTI.
What This Means for Canadian Patients
Canadian patients diagnosed with necrotizing soft tissue infections typically receive standard care including intravenous antibiotics and surgical removal of dead tissue. This review underscores the serious outcomes of these infections but does not offer insights into the potential benefits or role of hyperbaric oxygen therapy, as it was not part of their analysis.
Canadian Relevance
No direct Canadian connection identified, as the study was not conducted by Canadian authors or in Canada. Furthermore, the review explicitly excluded hyperbaric oxygen therapy, which is relevant to Canada Hyperbarics' focus.
Study Limitations
A significant limitation is the explicit exclusion of randomized controlled trials investigating hyperbaric oxygen therapy for necrotizing soft tissue infections.